drugset / Trial / NCT05304364
Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)
NaSequentialOpen-labelTreatment
Summary
This is an Open-Label Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Switching from Oral Naltrexone HCL to DLP-160 (Naltrexone implant) to Intramuscular Vivitrol®
Timeline
- Start
- 2022-03-22
- Primary completion
- 2022-10-21
- Completion
- 2022-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 50 mg | Oral |